XML 34 R27.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Sep. 26, 2025
Equity [Abstract]  
Schedule of Allocation of Share-Based Compensation Expense

The following table sets forth the detailed allocation of the share-based compensation expense which was included in the Company’s condensed consolidated statements of operations:

 

Three Months Ended

 

Nine Months Ended

(in thousands)

September 26, 2025

 

September 27, 2024

 

September 26, 2025

 

September 27, 2024

Cost of revenue

$

260

 

$

295

 

$

1,689

 

$

1,091

Research and development

 

1,904

 

 

1,804

 

 

5,601

 

 

5,282

Selling, general and administrative

 

5,160

 

 

3,611

 

 

16,196

 

 

13,214

Total

$

7,324

 

$

5,710

 

$

23,486

 

$

19,587

 

Schedule of Restricted Stock Units

(in thousands, except per share amounts)

Number of
Shares

 

Weighted Average
Grant-Date Fair
Value Per Share

Balance at December 31, 2024

 

3,447

 

$

12.95

Granted

 

3,148

 

 

8.71

Vested

 

(2,064)

 

 

12.59

Forfeited

 

(162)

 

 

12.90

Balance at September 26, 2025

 

4,369

 

$

10.07